Study Evaluation of Recombinant Hirudin in Prophylaxis of Post-Operative Deep Vein Thrombosis
NCT05847205
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Prophylaxis of Deep Vein Thrombosis
Interventions
DRUG:
r-Hirudin
Sponsor
MinaPharm Pharmaceuticals